1. Wang S, Saboorian MH, Frenkel EP, et al. Assessment of HER-2/neu status in breast cancer: Automated Cellular Imaging System (ACIS)-assisted quantitation of immunohistochemical assay achieves high accuracy in comparison with fluorescence in situ hybridization assay as the standard. Am J Clin Pathol. 2001;116:495-503.
2. McCormick SR, Lillemoe TJ, Beneke J, et al. HER2 assessment by immunohistochemical analysis and fluorescence in situ hybridization. Am J Clin Pathol. 2002;117:935-943.
3. Bofin AM, Yttherhus B, Martin C, et al. Detection and quantification of HER-2 gene amplification and protein expression in breast cancer. Am J Clin Pathol. 2004;122:110-119.
4. Lal P, Tan LK, Chen B. Correlation of HER-2 status with estrogen and progesterone receptors and histologic features in 3,655 invasive breast cancers. Am J Clin Pathol. 2005;123:541-546.
5. de Cremoux P, Coste J, Sastre-Garau X, et al. Efficiency of the Hybrid Capture 2 HPV DNA test in cervical cancer screening. Am J Clin Pathol. 2003;120:492-499.